PatientsVille.com Logo

PatientsVille
Prostaglandin Side Effects

Report Prostaglandin Side Effects

If you experienced any harmful or unwanted effects of Prostaglandin, please share your experience. This could help to raise awareness about Prostaglandin side effects, identify uknown risks and inform health professionals and patients taking Prostaglandin.

Examples: headache, dizziness


The most commonly reported Prostaglandin side effects are:
Post Menopausal Bleeding (3 reports)
SEVERE ABDOMINAL CRAMPING AND BLOATING (3 reports)
Severe Angioedema (2 reports)
Trouble (2 reports)
Breast Discharge (1 reports)
High Blood Sugar Count (1 reports)
SLUGGISH (1 reports)

If you have experienced a side effect listed above, you can check a box to report it.


View a complete list of Prostaglandin side effects or compare Prostaglandin side effects

If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (eg, physician, pharmacist). Your health care provider can provide additional clinical information and complete a copy of the side effect reporting form.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

'

Prostaglandin Side Effects Reported to FDA

The following Prostaglandin reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Prostaglandin on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Priapism
on May 28, 2012 Male from UNITED STATES , 55 years of age, was diagnosed with and was treated with Prostaglandin E1. Directly after, patient experienced the unwanted or unexpected Prostaglandin side effects: priapism. Prostaglandin E1 dosage: 1 Df, Unk.
Associated medications used:
  • Papaverine
  • Cialis (5 Mg, Qd)
  • Phentolamine Mesylate


Visual Impairment
Patient was taking Prostaglandin. Patient felt the following Prostaglandin side effects: visual impairment on Nov 16, 2011 from JAPAN Additional patient health information: Male , 50 years of age, . Prostaglandin dosage: Unk.
Multiple prescriptions taken:
  • Sanpilo (Unk)
  • Varenicline Tartrate (Unk)


Extremity Necrosis, Condition Aggravated, Raynaud's Phenomenon, Prothrombin Time Prolonged, Ischaemia, Gangrene, Multi-organ Failure
Adverse event was reported on Aug 25, 2011 by a Male taking Prostaglandins(prostaglandins) (Dosage: N/A) . Location: JAPAN , 69 years of age, After Prostaglandin was administered, patient encountered several Prostaglandin side effects: extremity necrosis, condition aggravated, raynaud's phenomenon, prothrombin time prolonged, ischaemia, gangrene, multi-organ failure.
Multiple concurrent drugs taken:
  • Gemcitabine (400.00-mg/m2, 80.00-mg-1.0days)
  • Gemcitabine (400.00-mg/m2, 80.00-mg-1.0days)
Patient was hospitalized.

Neonatal Asphyxia, Caesarean Section
on Jun 21, 2011 Female from JAPAN , weighting 6.77 lb, was diagnosed with and was treated with Prostaglandin F2 Alpha. Directly after, patient experienced the unwanted or unexpected Prostaglandin side effects: neonatal asphyxia, caesarean section. Prostaglandin F2 Alpha dosage: 3 Mg, 1x/day.
Associated medications used:
  • Cefaclor (250 Mg, 1x/day)
  • Unasyn (1.5 Mg, 1x/day)



Renal Disorder, Escherichia Infection, Renal Failure Acute, Fibroma, Septic Shock, Transplant Rejection, Thrombosis
on May 26, 2011 Female from FRANCE , 34 years of age, was treated with Prostaglandins. Patient felt the following Prostaglandin side effects: renal disorder, escherichia infection, renal failure acute, fibroma, septic shock, transplant rejection, thrombosis. Prostaglandins dosage: N/A.
Multiple prescriptions taken:
  • Mifepristone (mifeprex)
  • Methergine (Unk)
  • Cytotec
Patient was hospitalized.

Renal Failure Acute, Multi-organ Failure, Lymphocyte Count Increased, Pulmonary Oedema, Pyrexia, Cytokine Release Syndrome, Hypoxia, Shock
Patient was taking Prostaglandin E1. After Prostaglandin was administered, patient encountered several Prostaglandin side effects: renal failure acute, multi-organ failure, lymphocyte count increased, pulmonary oedema, pyrexia, cytokine release syndrome, hypoxia, shock on Mar 17, 2011 from KOREA, REPUBLIC OF Additional patient health information: Female , weighting 35.27 lb, was diagnosed with and. Prostaglandin E1 dosage: 10 Mcg, Unk.
Multiple concurrent drugs taken:
  • Acetaminophen (Unk)
  • Thymoglobulin (37.5 Mg, Qd)
  • Fludara
  • Corticosteroids (Unk)
  • Sol Medrol (15 Mg, Qd)
  • Thymoglobulin (Unk)
  • Fludara (25 Mg, Qd)
  • Melphalan
Patient was hospitalized.

Shock, Hypoxia, Pulmonary Oedema, Pyrexia, Lymphocyte Count Decreased, Renal Impairment, Hypotension
Adverse event was reported on Mar 08, 2011 by a Female taking Prostaglandin E1 (Dosage: 30 Mcg, Unk) was diagnosed with and. Location: KOREA, REPUBLIC OF , weighting 74.96 lb, Directly after, patient experienced the unwanted or unexpected Prostaglandin side effects: shock, hypoxia, pulmonary oedema, pyrexia, lymphocyte count decreased, renal impairment, hypotension.
Associated medications used:
  • Acetaminophen (Unk)
  • Tylenol (325 Mg, Qd)
  • Thymoglobulin (90 Mg, Qd)
  • Corticosteroids (Unk)
  • Solu-medrol (35 Unk, Unk)
  • Cyclophosphamide (1805 Mg, Qd)
  • Heparin (3600 Iu, Unk)
  • Antihistamines (Unk)


Hypoxia, Renal Impairment, Pyrexia, Hypotension, Pulmonary Oedema, Shock
on Jan 31, 2011 Female from KOREA, REPUBLIC OF , weighting 74.96 lb, was diagnosed with and was treated with Prostaglandin E1. Patient felt the following Prostaglandin side effects: hypoxia, renal impairment, pyrexia, hypotension, pulmonary oedema, shock. Prostaglandin E1 dosage: 30 Mcg, Unk.
Multiple prescriptions taken:
  • Thymoglobulin (2.5 Mg/kg, Unk)
  • Thymoglobulin (2.5 Mg/kg, Unk)
  • Heparin (3600 Iu, Unk)
  • Thymoglobulin (2.5 Mg/kg, Unk)
  • Cyclophosphamide (1805 Mg, Qd)


Multi-organ Failure, Pyrexia, Hypoxia, Blood Pressure Decreased, Renal Failure Acute, Cytokine Release Syndrome, Pulmonary Oedema, Shock
on Jan 31, 2011 Female from KOREA, REPUBLIC OF , weighting 35.27 lb, was diagnosed with and was treated with Prostaglandin E1. After Prostaglandin was administered, patient encountered several Prostaglandin side effects: multi-organ failure, pyrexia, hypoxia, blood pressure decreased, renal failure acute, cytokine release syndrome, pulmonary oedema, shock. Prostaglandin E1 dosage: 10 Mcg, Unk.
Multiple concurrent drugs taken:
  • Thymoglobulin (Unk)
  • Melphalan (90 Mg, Qd)
  • Melphalan
  • Fludara (25 Mg, Qd)
  • Fludara
  • Ranitidine (15 Mg, Q12hr)
  • Thymoglobulin (2.5 Mg/kg, Qd)
  • Heparin (1500 Iu, Unk)
Patient was hospitalized.

Cardiac Failure, Collateral Circulation
Patient was taking Prostaglandin E1 (prostaglandin E1). Directly after, patient experienced the unwanted or unexpected Prostaglandin side effects: cardiac failure, collateral circulation on May 25, 2010 from JAPAN Additional patient health information: Female , weighting 4.41 lb, was diagnosed with and. Prostaglandin E1 (prostaglandin E1) dosage: Gradually Increased To 8.0 Ng/kg/min.
Associated medications used:
  • Nitrogen, Liquid


Aorta Hypoplasia, Aortic Stenosis, Cardiac Failure, Cardiac Murmur, Cyanosis Neonatal, Mitral Valve Stenosis, Neonatal Cardiac Failure
Adverse event was reported on May 05, 2010 by a Female taking Prostaglandin E1 (prostaglandin E1) (Dosage: (gradually Increased To 8.0 Ng/kg/min)) was diagnosed with and. Location: JAPAN , weighting 4.41 lb, Patient felt the following Prostaglandin side effects: aorta hypoplasia, aortic stenosis, cardiac failure, cardiac murmur, cyanosis neonatal, mitral valve stenosis, neonatal cardiac failure.
Multiple prescriptions taken:
  • Nitrogen, Liquid


Enterocolitis
on Mar 26, 2010 Female from FRANCE , weighting 115.0 lb, was diagnosed with and was treated with Prostaglandin E1 (prostaglandin E1). After Prostaglandin was administered, patient encountered several Prostaglandin side effects: enterocolitis. Prostaglandin E1 (prostaglandin E1) dosage: (intravenous (not Otherwise Specified) ).

Feeding Disorder Neonatal, Iatrogenic Injury, Neonatal Respiratory Distress Syndrome, Obstruction Gastric, Tachycardia
on Mar 15, 2010 Female from POLAND , weighting 3.75 lb, was diagnosed with and was treated with Prostaglandin E1 (prostaglandin). Directly after, patient experienced the unwanted or unexpected Prostaglandin side effects: feeding disorder neonatal, iatrogenic injury, neonatal respiratory distress syndrome, obstruction gastric, tachycardia. Prostaglandin E1 (prostaglandin) dosage: (started At 0.05ug/kg/min And Reduced To 0.025ug/kg/min).

Diarrhoea Neonatal, Feeding Disorder Neonatal, Pyloric Stenosis, Vomiting Projectile
Patient was taking Prostaglandin E1 (prostaglandin). Patient felt the following Prostaglandin side effects: diarrhoea neonatal, feeding disorder neonatal, pyloric stenosis, vomiting projectile on Mar 15, 2010 from POLAND Additional patient health information: Female , weighting 7.50 lb, was diagnosed with and. Prostaglandin E1 (prostaglandin) dosage: (0.05ug/kg/min).

Cerebral Infarction, Chlamydial Infection, Disseminated Intravascular Coagulation, Finger Amputation, Gangrene, Haemorrhage, Heart Rate Increased, Myocarditis, Respiratory Rate Increased
Adverse event was reported on Oct 14, 2009 by a Female taking Prostaglandin E1 (Dosage: N/A) was diagnosed with and. Location: CHINA , 43 years of age, After Prostaglandin was administered, patient encountered several Prostaglandin side effects: cerebral infarction, chlamydial infection, disseminated intravascular coagulation, finger amputation, gangrene, haemorrhage, heart rate increased, myocarditis, respiratory rate increased.

Arteriospasm Coronary, Atrioventricular Block, Bradycardia, Cardiac Arrest, Electrocardiogram St Segment Depression, Electrocardiogram St Segment Elevation, Electrocardiogram T Wave Inversion, Hypotension, No Therapeutic Response
on Mar 19, 2009 Female from JAPAN , 60 years of age, weighting 119.0 lb, was diagnosed with and was treated with Prostaglandin E1 (prostaglandin E1). Directly after, patient experienced the unwanted or unexpected Prostaglandin side effects: arteriospasm coronary, atrioventricular block, bradycardia, cardiac arrest, electrocardiogram st segment depression, electrocardiogram st segment elevation, electrocardiogram t wave inversion, hypotension, no therapeutic response. Prostaglandin E1 (prostaglandin E1) dosage: (0.03 Ug/kg/min Intravenous (not Otherwise Specified).
Associated medications used:
  • Propofol ((intravenous (not Otherwise Specified)), (4 Mg/kg/h Intravenous (not Otherwise Specified))
  • Propranolol ((intravenous (not Otherwise Specified))
  • Fentanyl
  • Vecuronium Bromide
Patient was hospitalized.

Caesarean Section, Foetal Heart Rate Decreased, Hypotonia Neonatal, Neonatal Asphyxia
on Mar 04, 2008 Female from GERMANY , weighting 8.38 lb, was diagnosed with and was treated with Prostaglandin (pge2) (prostaglandin (pge2)). Patient felt the following Prostaglandin side effects: caesarean section, foetal heart rate decreased, hypotonia neonatal, neonatal asphyxia. Prostaglandin (pge2) (prostaglandin (pge2)) dosage: 3 Mg Once Vg.
Multiple prescriptions taken:
  • Oxytocin
Patient was hospitalized.

Caesarean Section, Neonatal Asphyxia
Patient was taking Prostaglandin. After Prostaglandin was administered, patient encountered several Prostaglandin side effects: caesarean section, neonatal asphyxia on Feb 21, 2008 from GERMANY Additional patient health information: Patient , weighting 8.38 lb, was diagnosed with and. Prostaglandin dosage: 3 Mg Once Transplacental.
Multiple concurrent drugs taken:
  • Oxytocin
Patient was hospitalized.

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Prostaglandin Side Effects

    Did You Have a Prostaglandin Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Prostaglandin for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    More About Prostaglandin

    Side Effects reported to FDA: 18

    Prostaglandin safety alerts: No

    Reported deaths: 3

    Reported hospitalizations: 2

    Latest Prostaglandin clinical trials